Starling Oncology, Inc. (STLN)

NASDAQ: STLN · Real-Time Price · USD

6.71

-0.20 (-2.89%)

Oct 23, 2026, 4:00 PM EDT - Market closed

Starling Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	684	350	23	150	123	714
Market Cap Growth	66.60%	1400.09%	-84.48%	22.52%	-82.81%	-
Enterprise Value	748	426	99	181	139	808
Last Close Price	6.71	3.56	0.31	2.04	1.65	9.75

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	-	1805.81	-
PS Ratio	1.16	0.70	0.06	0.46	0.49	3.52
PB Ratio	-	-22.28	6.51	2.64	1.00	6.86
P/TBV Ratio	-	-	-	4.72	1.47	12.05

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	1.27	0.85	0.25	0.56	0.55	3.98

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	-4.21	-6.65	34.53	2.10	0.88	0.00
Net Debt / Equity Ratio	-2.56	-4.51	20.69	0.65	0.28	-1.10
Net Debt / EBITDA Ratio	-3.30	-2.44	-1.38	-0.68	-0.51	2.71
Net Debt / FCF Ratio	-19.39	-2.55	-2.45	-0.90	-0.51	3.21
Asset Turnover	3.47	2.98	2.06	1.38	1.09	1.51
Inventory Turnover	27.66	31.68	28.62	23.08	25.53	30.05
Quick Ratio	1.14	1.31	1.88	3.62	3.84	4.55
Current Ratio	1.36	1.59	2.15	4.13	4.39	5.17
Return on Equity (ROE)	-	-	-213.36%	-92.20%	0.13%	-16.52%
Return on Assets (ROA)	-9.65%	-13.37%	-19.67%	-15.97%	-19.35%	-21.08%
Return on Invested Capital (ROIC)	-30.31%	-42.07%	-70.03%	-47.85%	-97.58%	-377.00%
Return on Capital Employed (ROCE)	-31.30%	-38.50%	-49.90%	-34.50%	-31.00%	-26.10%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-4.53%	-17.30%	-276.96%	-55.21%	0.12%	-1.53%
FCF Yield	-0.48%	-7.93%	-129.89%	-27.17%	-54.80%	-4.98%
Buyback Yield / Dilution	-25.63%	-23.11%	-1.76%	8.51%	-21.70%	-12.03%

SEC Filings: 10-K · 10-Q